The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 08, 2020

Filed:

May. 30, 2017
Applicants:

Centre Hospitalier Universitaire D'angers, Angers, FR;

Université D'angers, Angers, FR;

Inventor:

Paul Cales, Avrille, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G16B 5/00 (2019.01); G01N 33/68 (2006.01); G16H 50/20 (2018.01); G01N 33/576 (2006.01); G16H 50/30 (2018.01); G01N 33/574 (2006.01); A61K 31/00 (2006.01); G01N 33/50 (2006.01); A61K 31/4178 (2006.01); A61K 38/21 (2006.01);
U.S. Cl.
CPC ...
G16B 5/00 (2019.02); A61K 31/00 (2013.01); G01N 33/50 (2013.01); G01N 33/576 (2013.01); G01N 33/57438 (2013.01); G01N 33/6893 (2013.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); A61K 31/4178 (2013.01); A61K 38/21 (2013.01); G01N 2333/4713 (2013.01); G01N 2333/495 (2013.01); G01N 2333/78 (2013.01); G01N 2400/40 (2013.01); G01N 2800/085 (2013.01); G01N 2800/52 (2013.01); G01N 2800/60 (2013.01); G01N 2800/7052 (2013.01);
Abstract

A method for implementing an adapted patient care for an individual suffering from liver fibrosis after assessing liver fibrosis progression in the individual, and thus determining whether the individual is a slow, medium or fast fibroser. Also, a method for treating an individual suffering from liver fibrosis and identified as a fast fibroser, which includes the steps of identifying the individual as a fast fibroser by assessing fibrosis progression and treating the individual by administering without delay at least one therapeutic agent for treating liver fibrosis, or for treating the underlying cause responsible for liver fibrosis, or both.


Find Patent Forward Citations

Loading…